Meningococcal meningitis
ICD-10 A39.0 is a billable code used to indicate a diagnosis of meningococcal meningitis.
Meningococcal meningitis is a severe bacterial infection of the protective membranes covering the brain and spinal cord, caused by Neisseria meningitidis. This condition is characterized by the rapid onset of symptoms such as fever, headache, stiff neck, nausea, vomiting, and altered mental status. Meningococcal meningitis can lead to serious complications, including septicemia, hearing loss, and neurological damage. The disease is transmitted through respiratory droplets and is particularly prevalent in crowded settings such as college dormitories and military barracks. Diagnosis is typically confirmed through lumbar puncture and cerebrospinal fluid analysis, which reveals an elevated white blood cell count, elevated protein levels, and decreased glucose levels. Prompt treatment with intravenous antibiotics, such as ceftriaxone or penicillin, is critical to improve outcomes and reduce mortality. Vaccination against Neisseria meningitidis is an effective preventive measure, especially in high-risk populations.
Detailed clinical history, laboratory results, and treatment protocols must be documented.
Diagnosis and management of meningococcal infections, including outbreak response.
Ensure accurate documentation of vaccination status and exposure history.
Neurological examination findings and imaging results should be included.
Evaluation of neurological deficits following meningitis.
Document any long-term sequelae or complications resulting from the infection.
Used to obtain CSF for analysis in suspected meningitis cases.
Document indication for procedure and findings.
Neurology and Infectious Disease specialists should ensure thorough documentation of CSF analysis.
Common symptoms include sudden onset of fever, headache, stiff neck, nausea, vomiting, and altered mental status. A rash may also be present in some cases.
